An interventional study of Physical activity intervention and Standard of care in Depression, Anxiety, sponsored by University of Sao Paulo General Hospital. Recruiting at 2 sites in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-25.
Sponsored by University of Sao Paulo General Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 100 studies in Depression with a site in Brazil — 19 open to participants now, 24 under way, 3 of them phase 3. Depression · Brazil.
Among the 100 studies in Depression with a site in Brazil, this one is the 44th largest by planned enrollment of the 91 interventional ones that give a count, is one of 5 that started in 2025, is one of 62 with no phase, reaches primary completion later than 10 of the 23 other live ones, and was the 87th registered.
8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.
Browse Depression studies →19 of the 100 studies in Depression with a site in Brazil are open now. Recruiting first, the newest first:
University of Sao Paulo · Sites in Brazil
Ages 18–40 · Women only
Eli Lilly and Company · Sites in Brazil, United States, Australia and 12 more countries
Ages 18–75
Federal University of Minas Gerais · Sites in Brazil
Ages 18+ · Women only
Eli Lilly and Company · Sites in Brazil, United States, Australia and 12 more countries
Ages 18–75
Universidade Federal de Goias · Sites in Brazil
Ages 18+
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
100 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 13 · Phase 3 15 · Phase 4 3
First in 2005; this study’s year is marked. 5 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 84 is close to the median of 81 across 7,089 interventional studies indexed under Depression.
Median enrollment 80 across the 91 interventional studies, 120 across the 9 observational. Of the 48 that completed or were terminated, 9 (19%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 100 have an industry lead sponsor. The 10 most frequent:
University of Sao Paulo General Hospital is the lead sponsor of 612 studies on the registry; 99 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
University of Sao Paulo General Hospital has 9 studies filed under Depression — fewer than ten, so there is no comparison to draw.
7 of the studies in Depression with a site in Brazil that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07480668Federal University of Minas GeraisAromatherapy for Mental Health Promotion in IVF Patients | 2026-12 |
| NCT06636006Universidade Federal de GoiasAerobic Exercise Versus Digital Cognitive Behavioral Therapy for Insomnia | 2026-12-30 |
| NCT06692842University of Sao Paulo General HospitalInteractive Technological Intervention to Improve Mental Health Symptoms in Primary Health Care | 2026-12-31 |
| NCT06480019Hospital de Clinicas de Porto AlegreIPT-based Group Intervention by Non-specialist for Improvement of Depressive Symptoms in Community Young Adults in Brazil | 2026-12-31 |
| NCT07925762University of Sao PauloSmartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression | 2027-06-01 |
Add all 7 to your calendar (.ics) → With an account.
Among the 100 studies in Depression with a site in Brazil, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Depressive symptoms are commonly observed in the general population. Individuals with subclinical forms of depression (e.g., not meet the criteria to major depression disorder) are at increased risk of mortality than the general population which is partially explained by the higher incidence of cardiovascular diseases. Currently, the effectiveness of the frontline treatment for depression is not consensual. Further, it also may be expensive for individuals with mild to moderate depression. Sedentary behavior is an independent risk factor for cardiometabolic diseases and mental disorders. However, recent evidence suggests that not all types of sedentary behavior are equally detrimental. For instance, mentally passive sedentary behavior (e.g., watching TV) appear to be detrimental for health outcomes whereas mentally active sedentary behavior (e.g., desk-based office work) appear to offer health benefits. However, more studies are required to determine the magnitude of association between distinct types of sedentary behaviors (e.g., watching TV, listening to music, talking while sitting, sitting around and doing nothing special) with depressive symptoms as well as randomized clinical trials investigating potential benefits of interventions to replace mentally-passive sedentary behaviors with mentally active sedentary behaviors, light physical activity or moderate-to-vigorous activity in individuals with mild to moderate depression. Therefore, the aim of this proposal is to investigate the influence of mentally passive sedentary behavior (i.e., watching TV, listening to music, talking while sitting, sitting around, and doing nothing special) on depressive symptoms. This is a randomized clinical trial. Participants with mild to severe depressive symptoms will be randomly assigned (1:1) into either INTERVENTION or CONTROL group, using a computer-generated randomization code. Depressive symptoms, quality of life, physical activity, sedentary behavior, body composition, and functionality will be assessed at baseline (PRE) and 4 (POST) months after the experimental period. The INTERVENTION group will participate in a 4-month goal-setting intervention aimed to replace mentally passive sedentary behaviors with mentally active sedentary behaviors, light physical activity, or moderate-to-vigorous activity while CONTROL group will receive general instructions related to WHO guidelines for physical activity.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients allocated to this arm will be submitted to intervention (4-month goal-setting intervention aimed to replace mentally passive sedentary behaviors with mentally active sedentary behaviors, light physical activity, or moderate-to-vigorous activity)
Behavioral: Physical activity intervention
Patients allocated to this arm will be submitted to intervention (4 face-to-face individual sessions during 4 months, lasting \~15-30 minutes, however they will receive general instructions related to WHO guidelines for physical activity.)
Behavioral: Standard of care
The INTERVENTION group will participate in a 4-month goal-setting intervention aimed to replace mentally passive sedentary behaviors with mentally active sedentary behaviors, light physical activity, or moderate-to-vigorous activity.
The CONTROL group also will participate of 4 face-to-face individual sessions during the experimental period, lasting \~15-30 minutes, however they will receive general instructions related to WHO guidelines for physical activity
Depressive Symptoms
The depressive symptoms will be assessed by Beck's Depressive Inventory (BDI). Score ranges from 0 to 63 points, being higher scores indicative of higher symptoms of depression.
Time frame: Baseline (Pre-intervention) and 16 weeks (Post-intervention)
Anxiety Symptoms (primary outcome)
The anxiety symptoms will be assessed by Beck's Anxiety Inventory (BAI).Score ranges from 0 to 63 points, being higher scores indicative of higher symptoms of anxiety.
Time frame: Baseline (Pre-intervention) and 16 weeks (Post-intervention)
Indirect physical activity levels assessment
Indirect Physical activity levels will be assessed using the International Physical Activity Questionnaire-Long Form (IPAQ).
Time frame: Baseline (Pre-intervention) and 16 weeks (Post-intervention)
Objective physical activity levels assessment
Objective measures of physical activity levels will be assessed using ActiGraph GT9X® accelerometers
Time frame: Baseline (Pre-intervention) and 16 weeks (Post-intervention)
Indirect sedentary behavior assessment
Indirect levels of sedentary behavior will be assessed using the questionnaire LASA-SBQ (i.e., Longitudinal Aging Study Amsterdam - Sedentary Behavior Questionnaire).
Time frame: Baseline (Pre-intervention) and 16 weeks (Post-intervention)
Objective sedentary behavior assessment
The objective measures of sedentary time will be assessed using ActiGraph GT9X® accelerometers.
Time frame: Baseline (Pre-intervention) and 16 weeks (Post-intervention)
Quality of life assessement
The quality of life will be assessed using the WHOQOL-bref. Score ranges from 0 to 100 points, being higher scores indicative of higher quality of life.
Time frame: Baseline (Pre-intervention) and 16 weeks (Post-intervention)
Body Weight
Body weight will be assessed on a calibrated digital scale.
Time frame: Baseline (Pre-intervention) and 16 weeks (Post-intervention)
Fat mass (kg)
Fat mass (kg) will be assessed using 4-point bioelectrical impedance device (hands and feet).
Time frame: Baseline (Pre-intervention) and 16 weeks (Post-intervention)
Fat-free mass (kg)
Fat-free mass (kg) will be assessed using 4-point bioelectrical impedance device (hands and feet).
Time frame: Baseline (Pre-intervention) and 16 weeks (Post-intervention)
Muscle Function (30-s Sit-to-stand Test)
The 30-second sit-to-stand test is a simple measure of lower body strength and functional capacity. Participants are asked to rise from a seated position and sit back down as many times as possible within 30 seconds. The total number of complete sit-to-stand repetitions performed in the given time is recorded. This test is commonly used to assess physical fitness and mobility, particularly in older adults or individuals with health conditions.
Time frame: Baseline (Pre-intervention) and 16 weeks (Post-intervention)
Muscle Function (Timed-up-and-go)
The Timed Up and Go (TUG) test is a simple and widely used assessment of mobility and balance. Participants are asked to stand up from a seated position, walk 3 meters, turn around, walk back to the chair, and sit down again, all as quickly as possible. The total time taken to complete the task is recorded. The TUG test is commonly used to evaluate functional mobility, fall risk, and the ability to perform daily activities, particularly in older adults or individuals with mobility impairments.
Time frame: Baseline (Pre-intervention) and 16 weeks (Post-intervention)
Started Jun 2025 (actual). Primary completion is estimated for Jul 2026, 13 months after the start.
Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 13 months is below that.
Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Sao Paulo General Hospital →